Eha Lotion
FDA Label NDC 76420-351

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Asclemed Usa, Inc. for the product Eha (NDC 76420-351). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredients, purpose, uses, warning, stop using this product and ask doctor if, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Drug Facts

Active Ingredients

Lidocaine HCI 4%

Purpose

External Anesthetic

Uses

For temporary relief of pain and itching and minor skin irritations due to minor cuts and scrapes, sunburns, and minor burns.

Warning

For external use only.

Avoid contact with eyes

Stop Using This Product And Ask Doctor If

  • symptoms last for more than seven days, or clear up and occur again within a few days
  • if redness, irritation, swelling, pain or other symptoms increase

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For adults and children two-years or older, apply externally to the affected area. Do not use more than three to four times per day.

Inactive Ingredients

Inactive ingredients: Aqua (Deionized Water), C13-14 Isoparaffin, Glyceryl Stearate, Helianthus Annuus (Sunflower) Seed Oil, Isopropyl Myristate, Laureth-7, M Polyacrylamide, Steric Acid.

Principal Display Panel - 88 Ml Bottle Label

‘Eha Lotion 4%

Pain Relief Lotion

For Professional Use Only

3 OZ (88 mL)

Distributed by

Enovachem

PHARMACEUTICALS

Torrance, CA 90501

(310) 320-0100

Principal Display Panel (Eha01 0000 01)

Principal Display Panel (Eha01 0000 01)

* Please review the disclaimer below.